H

Hyphens Pharma International Ltd
SGX:1J5

Watchlist Manager
Hyphens Pharma International Ltd
SGX:1J5
Watchlist
Price: 0.285 SGD
Market Cap: 88.1m SGD
Have any thoughts about
Hyphens Pharma International Ltd?
Write Note

Hyphens Pharma International Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hyphens Pharma International Ltd
Cost of Revenue Peer Comparison

Comparables:
WVE
H02
I
42C

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
H
Hyphens Pharma International Ltd
SGX:1J5
Cost of Revenue
-S$126.9m
CAGR 3-Years
-17%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
WAVE Life Sciences Ltd
NASDAQ:WVE
Cost of Revenue
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Haw Par Corporation Ltd
SGX:H02
Cost of Revenue
-S$102.7m
CAGR 3-Years
-22%
CAGR 5-Years
0%
CAGR 10-Years
-5%
I
IX Biopharma Ltd
SGX:42C
Cost of Revenue
-S$4.9m
CAGR 3-Years
-32%
CAGR 5-Years
-33%
CAGR 10-Years
N/A

See Also

What is Hyphens Pharma International Ltd's Cost of Revenue?
Cost of Revenue
-126.9m SGD

Based on the financial report for Jun 30, 2024, Hyphens Pharma International Ltd's Cost of Revenue amounts to -126.9m SGD.

What is Hyphens Pharma International Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-11%

Over the last year, the Cost of Revenue growth was -31%. The average annual Cost of Revenue growth rates for Hyphens Pharma International Ltd have been -17% over the past three years , -11% over the past five years .

Back to Top